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Echium hypertropicum Webb and Echium stenosiphon Webb subsp. stenosiphon are cape-
verdian shrubs used in folk medicine for the treatment of cough and gastrointestinal
diseases. Acid-base extraction was used to obtain alkaloid-rich fractions from both species.
GC–MS and ESI-MS/MS analysis indicated the presence of pyrrolizidine alkaloids (PAs) and
puriﬁed substances were also analyzed by 1D and 2D NMR experiments. A total of ten
alkaloids were detected, eight of which were identiﬁed by comparing their molecular
masses and mass fragmentation patterns with the NIST database and data in the literature.
The hepatotoxic diesters echimidine and 7-(2-methylbutyryl)-9-echimidinylretronecine
were identiﬁed in both species. Echimidine was the major component in the diethyl
ether fraction from leaves of E. hypertropicum, whereas the 7-(2-methylbutyryl)-9-
echimidinylretronecine was the major component in the dichloromethane fraction from
leaves of E. stenosiphon. To our knowledge, this is the ﬁrst report on the occurrence of
pyrrolizidine alkaloids in capeverdian species of Echium. This study on Echium led to the
identiﬁcation of constituent pyrrolizidine alkaloids, serving to assist taxonomists with the
complex taxonomy of this genus.
 2013 Elsevier Ltd. All rights reserved.1. Introduction
Several plant species contain pyrrolizidine alkaloids (PAs) with known toxicity (Mehrabani et al., 2006; Crews et al., 2010)
such as the 1,2 unsaturated PAs described as hepatotoxic, carcinogenic, mutagenic, teratogenic and pneumotoxic (Culvenor
et al., 1976; Fu et al., 2002; Mehrabani et al., 2006; Mattsson, 2007; Zamansoltani et al., 2008). The genus Echium (Bor-
aginaceae) contains 66 species native to North Africa, Southern Africa, Europe, Macaronesian Archipelagos, the Iberian
Peninsula and Eastern Mediterranean (Gibbs, 1971; The Plant List, 2012). There are 27 species of Echium endemic to thes spectrometry; ESI–MS/MS, electrospray ionization tandem mass spectrometry.
fax: þ55 21 2629 9578.
. All rights reserved.
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of Cape Verde and the remainder on the Canary Islands. All the species studied to date contain toxic PAs such as Echium
pininana (Roeder et al., 1991), Echium setosum (El-Shazly et al., 1996a), Echium humile (El-Shazly et al., 1996b), Echium hor-
ridum and Echium rauwolﬁ (El-shazly et al., 1999), Echium plantagineum (Culvenor, 1956; Culvenor et al., 1981; Colegate et al.,
2005), Echium vulgare (El-Shazly et al., 1996a; Boppré et al., 2005), Echium amoenun (Mehrabani et al., 2006) and Echium
glomeratum (Alali et al., 2008). Gamma-linolenic acid was found in oil from seeds of three Capeverdian species of Echium
(Guil-Guerrero et al., 2006). However, to our knowledge, no previous studies have been conducted regarding the investigation
of alkaloids in Capeverdian species of Echium.
Echium stenosiphon subsp. stenosiphon Webb is a 1.0 m-tall shrub with a brown stem covered by long and rigid, ovate or
lanceolate leaves up to 10 cm long and 5 cmwide. It has inﬂorescences with few ﬂowers and is found only in the North Island
of Cape Verde (Santo Antão, São Vicente and São Nicolau) from an altitude of 500 m (Gomes et al., 2003; Romeiras et al.,
2008).
Echium hypertropicum Webb is a 2.5 m-tall shrub, highly branched, with young branches covered by long and hard
lanceolate leaves measuring 20 cm long and 5 cmwide. It displays dense inﬂorescence with small whitish, purplish or bluish
ﬂowers. It is found only in the South Capeverdian Islands (Santiago and Brava) from an altitude of 700 m (Gomes et al., 2003;
Romeiras et al., 2008).
E. stenosiphon subsp. stenosiphon and E. hypertropicum, commonly known as “lingua-de-vaca” or “lingua-di-baca”,
respectively, are used in traditional medicine for the treatment of cough and gastrointestinal diseases (Gomes et al., 2003,
2008; Romeiras et al., 2008). Despite its use in folk medicine, to our knowledge, the chemical constituents of these two
capeverdian Echium species remain unexplored. This prompted us to undertake a proﬁling study of the alkaloids in E.
stenosiphon subsp. stenosiphon and E. hypertropicum.
2. Materials and methods
2.1. Plant material
Leaves of E. stenosiphon Webb subsp. stenosiphon were collected in February 2011 at the Parque Natural de Monte Gordo
(PNMG) (0784118/1839654), Cape Verde. A voucher specimen (RFFP 13799) has been deposited at the Herbarium of the
Faculdade de Formação de Professores, Universidade do Estado do Rio de Janeiro, Brazil. Leaves of E. hypertropicum Webb
were collected in February 2011 at Santiago Island in the district of Biscaínhos-Tarrafal, Cape Verde. A voucher specimen (RFFP
13798) has also been deposited at the above-mentioned Herbarium.
2.2. Preparation of the ethanolic extract
Air dried (25 C) leaves of E. hypertropicum (5.55 kg) and E. stenosiphon (5.50 kg) were powdered and exhaustively
extracted at room temperature with EtOH 96% (v/v) by maceration and percolation, respectively. After evaporation under
reduced pressure, the two crude ethanolic extracts yielded 158.0 g and 176.0 g, respectively.
2.3. Alkaloid extraction
2.3.1. Pyrrolizidine alkaloids of E. hypertropicum
Ethanolic extract (45.0 g) from E. hypertropicumwas shaken for 15minwith 500mL of 0.1 N H2SO4 and ﬁltered. This ﬁltrate
was extracted using dichloromethane (3  100 mL). The dichloromethane fraction tested negative with the Dragendorff’s
reagent, indicating an absence of hydrochloride salts of the alkaloids in the organic solvent. The acidic aqueous residue was
made alkaline (pH 10) with the addition of 25% NH4OH, and then partitioned using diethyl ether (5  250 mL). This partition
furnished, after drying with anhydrous sodium sulfate and evaporation under reduced pressure, 74.3 mg of diethyl ether
fraction. Alkaline aqueous residue was then partitioned with dichloromethane (5  100 mL) and n-butanol (4  250 mL) to
afford, after the same treatment, 38.3 mg of dichloromethane fraction and 2.1 g of n-BuOH fraction, respectively. The diethyl
ether fractionwas chromatographed on a Sephadex LH-20 columnwithMeOH to yield 10 fractions, based on TLC analysis. A
further separation on a Sephadex LH-20 column from the alkaloid-rich fraction 1 (40.0 mg) furnished the isolated com-
pound V (17.0 mg). The TLC plates were developed using toluene/ethyl acetate/diethylamine (7:2:1) and then revealed with
Dragendorff’s reagent and H2SO4 10% in MeOH.
2.3.2. Pyrrolizidine alkaloids of E. stenosiphon
Ethanolic extract (56.0 g) from E. stenosiphonwas shaken for 15 min with 840 mL of 0.1 N H2SO4 and ﬁltered. This ﬁltrate
was extracted using dichloromethane (3 100mL). The dichloromethane-soluble fraction tested negative with Dragendorff’s
reagent, indicating an absence of hydrochloride salts of the alkaloids in the organic solvent. The acidic aqueous residue was
made alkaline (pH 10) with the addition of 25% NH4OH and then partitioned using diethyl ether (3  150 mL). This partition
furnished, after drying with anhydrous sodium sulfate and evaporation under reduced pressure, 50.0 mg of diethyl ether
fraction. The alkaline aqueous residue was then partitioned with dichloromethane (5  250 mL) and n-butanol (4  250 mL)
to afford, after the same treatment, 231.0 mg of dichloromethane fraction and 3.4 g of n-BuOH fraction. The dichloromethane
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analysis. Compound VI (59.0 mg) was isolated by a further separation on a Sephadex LH-20 column from the alkaloid-rich
fraction 2 (145.0mg). The TLC plates were developed using toluene/ethyl acetate/diethylamine (7:2:1) and then revealedwith
Dragendorff’s reagent and H2SO4 10% in MeOH.2.4. Analysis of the alkaloidal fraction and puriﬁed substances
2.4.1. NMR experiments
The NMR spectra were recorded on a Varian VNMRS 300 MHz spectrometer operating at 300 (1H) and 75 (13C) MHz.
Chemical shifts are reported as d values (ppm) with the residual solvent signal as the internal reference, with J expressed in
Hz. Deuterated chloroform was obtained from the Cambridge Isotope Laboratories (USA) and used for solubilization.
2.4.2. ESI-MS/MS analysis
ESI-Q TOF MS spectra were obtained in positive mode on a QTOF Micro mass spectrometer (Waters, Manchester, U.K.) in
smart tube mode with capillary voltage set at 3.5 kV, cone voltage at 30 V, source temperature at 100 C and temperature of
desolvation at 120 C. The samples were introduced by infusion in a MeOH solution.
2.4.3. GC–MS
GC–MS analyseswere carried out on a GCMS-QP5000 (SHIMADZU)mass spectrometer using electron ionization, equipped
with an RTX-5 bonded capillary column (i.d. ¼ 0.25 mm, length 30 m, ﬁlm thickness ¼ 0.25 mm). The gas chromatographic
(GC) conditions were: injector temperature, 250 C; detector temperature, 250 C; He as carrier gas; ﬂow rate 1 mL/min;
samples were injected (1 ml) in split mode (split ratio,1:10). The temperature programwas as follows: 150–300 C at 6 C/min.
Mass spectra were recorded at 70 eV and a scan rate of 1 scan/s. MS fragmentation patterns were checked against the NIST
mass spectra library.
3. Results and discussion
3.1. Echium hypertropicum
TLC analysis of diethyl ether fraction showed yellow spots on TLC plates after treatment with Dragendorff’s reagent,
suggesting the presence of alkaloids. The GC–MS chromatogram of this fraction showed seven different compounds (I–VII)
with a typical fragmentation pattern of pyrrolizidine alkaloids, when compared to the library of the National Institute of
Standards and Technology (NIST).
Compound I showed signiﬁcant fragment ions at m/z 137, 124, 111, 106, 94 and 80 (base peak) typical of 1,2-unsaturated
necine monoesters at C-7 (Witte et al., 1993; El-Shazly et al., 1996b). Based upon the mass fragmentation data previously
reported, compound I was identiﬁed as 7-senecioylretronecine. The relative conﬁguration of the identiﬁed compound was
established by comparing with literature data.
Compound II differed from V by the replacement of the allylic ester unit by a hydroxyl group. This was revealed by the
fragment ion at m/z 138 which results from the cleavage of the weak allylic ester bond [M - C5H8O2]þ. In addition, the mass
spectrum showed key fragments atm/z 138, 137, 136 and 93 (base peak), characteristic of 1,2-unsaturated necine monoesters
at C-9 (Witte et al., 1993). Compound II was identiﬁed unequivocally as 9-angeloylretronecine by comparing its mass frag-
mentation pattern against deﬁned reference data from the database and also by comparisonwith literature data (Witte et al.,
1993). The relative conﬁguration of the identiﬁed compound was established by comparing with literature data.
Compound III showed a base peak atm/z 138 due to cleavage of the weak allylic ester bond, providing strong evidence for
the presence of a free OH at C-7. The fragmentation pattern of compound III was compared with literature data (Witte et al.,
1993; El-Shazly et al., 1996b) and conﬁrmed to be identical to lycopsamine. The relative conﬁguration of the identiﬁed
compound was established by comparing with literature data.
Compound IV exhibited a base peak atm/z 180, typical of 7-acetyl esters. The presence of the ion atm/z 43 and the absence
of the ion atm/z 83 and 55 provide good evidence for the presence of acetate at C-7 and also for the absence of angelic acid or
its isomers (El-Shazly et al., 1996a). Therefore, compound IV was identiﬁed as 7-acetyl-lycopsamine. The relative conﬁgu-
ration of the identiﬁed compound was established by comparing with literature data.
Compound Vwas the major component and exhibited a series of ions atm/z 136, 120, 119, 93, and 80, characteristic of 1,2-
unsaturated pyrrolizidine diesters (Pedersen and Larsen, 1970; El-Shazly et al., 1996b). The base peak atm/z 220 is due to the
cleavage of the weak allylic ester bond at C-9. In addition, compound V was further isolated using the chromatographic
method by including Sephadex LH-20 from the diethyl ether fraction. The structure of V was established by spectroscopic
methods, mainly MS, 1D and 2D-NMR experiments. The 13C NMR spectrum of V exhibited signals at d 131.96 and 126.32,
indicating a double bond between C-1 and C-2. The signals at d 73.36 (C-8), 72.13 (C-7), and 32.61 (C-6) are characteristic of
the presence of a retronecine diester (Roeder et al., 1991). The 1H NMR spectrum showed chemical shifts of the necine proton
at d 5.92 (H-1), 2.02 (H-6); 5.33 (H-7); 4.48 (H-8) and 4.88 (H-9) in agreement with the values reported for the retronecine
skeleton of acyclic diester alkaloids (Logie et al., 1994). Thus, compound V was conﬁrmed to be identical to echimidine by
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relative conﬁguration of the identiﬁed compound was established by comparing with literature data.
Compound VI revealed fragments at m/z 222 (base peak), 136, 120, 93 and m/z 80, characteristic of 1,2-unsaturated pyr-
rolizidine diesters (Pedersen and Larsen, 1970). The fragment atm/z 297 results from the loss of the acid attached to C-7 [M-
C5H10O2]þ and the ion at m/z 222 from the cleavage of the weak allylic ester bond [M- echimidinic acid (C7H14O5)]þ. The
fragment at m/z 59 corresponds to the radical C3H7O while both m/z 85 and 57 correspond to the saturated acid at C-7 (2-
methylbutanoic acid). Compound VI was identiﬁed as 7-(2-methylbutyryl)-9-echimidinylretronecine. The relative conﬁgu-
ration of the identiﬁed compound was established by comparing with literature data.
Compound VII exhibited a base peak at m/z 220 and also the ion series, m/z 136, 120, 119, 93 and 80, characteristic of 1,2-
unsaturated diester pyrrolizidine alkaloids (Pedersen and Larsen,1970; El-Shazly et al., 1996b). The base peak atm/z 220 is the
result of cleavage of the weak allylic ester bond and the ion atm/z 297 is due to loss of the acid attached at C-7 (Pedersen and
Larsen, 1970). The fragmentation pattern is similar to the alkaloid V, differing only in terms of the relative intensity of peaks
(see Table 1). The fragmentation pattern of VII is in agreement with those described in the literature (El-Shazly et al., 1996b)
for echihumiline or 7-senecioyl-9-echimidinylretronecine. The relative conﬁguration of the identiﬁed compound was
established by comparing with literature data (Fig. 1).
3.2. Echium stenosiphon subsp. stenosiphon
ESI-Q TOF MS analysis of the dichloromethane fraction led to the identiﬁcation of 7-(2-methylbutyryl)-9-
echimidinylretronecine (VI) as a major component at m/z 400 [M þ H]þ corresponding to C20H33NO7 and of another
component as echimidine (V) atm/z 398 [Mþ H]þ corresponding to C20H31NO7. These structurally similar alkaloids are based
on the necine base retronecine (unsaturation at 1,2 position). The major component VI was also isolated from the
dichloromethane fraction by separation on a Sephadex LH-20 column and analyzed by ESI-Q TOF MS. The MS spectrum of
the pure compound VI conﬁrmed the molecular weight asm/z 400 [M þ H]þ and also showed the characteristic fragments at
m/z 222 [400 – C7H14O5]þ andm/z 120 [400 – C7H14O5 – C5H10O2]þwhich correspond to the ions resulting from fragmentation
at C-9 and C-7, respectively. The structure of VIwas further conﬁrmed by 1H and 13C NMR data analysis and comparisonwith
1H and 13C literature assignments of necine (Roeder, 1990; Logie et al., 1994). The 13C NMR spectrum of VI exhibited signals at
d 132 and 126, indicating a double bond between C-1 and C-2 (El-Shazly et al., 1996a). The signals at d 76.07 (C-8), 73.59 (C-7),
and 34.07 (C-6) conﬁrmed the presence of a retronecine diester (Roeder et al., 1991). Thus, compound VIwas identiﬁed as 7-
(2-methylbutyryl)-9-echimidinyl retronecine as previously identiﬁed in Echium genus from the E. humile species (El-Shazly
et al., 1996b).
ESI-MS/MS spectrum analysis of the dichloromethane fraction showed the protonated molecule at m/z 398 which cor-
responds to echimidine (V) given MS/MS analysis of m/z 398 generated fragments at m/z 220 and m/z 120, characteristic for
this compound. The fragment ions at m/z 220 and m/z 120 are likely due to the loss of the acid attached at C-9 and C-7,
respectively. In addition, another MS/MS analysis of the protonated molecule at m/z 416 showed no ion at m/z 120 (100%)
corresponding to the ion formed by the necine base (cleavage at C-7 and C-9) as found in V and VI, suggesting this molecule
has a different necine base. The ion atm/z 416 (VIII) is 16mass units higher than VI, allowing its identiﬁcation as an N-oxide of
VI. The relative conﬁguration of the identiﬁed compound was established by comparing with literature data. The mass
fragmentation pattern of m/z 416 showed fragments at m/z 416 (30% rel. int) [M þ H]þ, m/z 398(37), 354(30), 256(100),
222(18), 137(12) and m/z 120(6). The existence of an N-oxide indicates that the reduction process was not carried out and/or
that 7-(2-methylbutyryl)-9-echimidinylretronecine N-oxide (VIII) was very stable. To our knowledge, this is the ﬁrst time the
compound (VIII) has been identiﬁed in the Echium genus.Table 1
Pyrrolizidine alkaloids identiﬁed in E. hypertropicum by GC–MS
Alkaloid [Mþ] Characteristic ions m/z (relative abundance) aLit.
7-senecioylretronecine 237 149 (3), 137 (17), 136 (16), 124 (17), 111 (29), 106 (41), 94 (29), 85 (5), 83 (9), 80 (100),
68 (8), 57 (2), 55 (12).
2
9-angeloylretronecine 237 219 (<1), 193 (5), 154 (20), 138 (30), 137 (25), 136 (13), 126 (10), 94 (37), 93 (100),
83 (8), 80 (15), 67 (8), 55 (10).
1, 3
Lycopsamine 299 299 (<1), 254 (1), 156 (5), 139 (21), 138 (100), 137 (14), 136 (16), 120 (12), 108 (5),
95 (11), 94 (67), 93 (97), 80 (19), 67 (10), 45 (1), 43 (22).
2, 3
7-acetyl-lycopsamine 341 341 (<1), 198 (10), 181 (29), 180 (100), 179 (7), 136 (21), 121 (28), 120 (80), 119 (13),
101 (39), 95 (10), 80 (20), 94 (38), 93 (63), 79 (3), 73 (7), 67 (8), 45 (4), 43 (23).
2
Echimidine 397 238 (10), 221 (29), 220 (100), 219 (4), 141 (37), 138 (8), 137 (7), 136 (48), 121 (38), 120 (79),
119 (20), 106 (9), 94 (44), 93 (63), 83 (43), 80 (16), 67 (5), 55 (18), 45 (3), 43 (10).
2
Echihumiline 397 238 (3), 221 (22), 220 (100), 219 (4), 141 (32), 138 (6), 137 (6), 136 (53), 121 (20), 120 (65),
119 (21), 118 (6), 106 (6), 95 (6), 94 (45), 93 (50), 83 (35), 80 (13), 67 (5), 59 (3), 55 (17),
53 (4), 43 (10), 41 (3)
2
7-(2-methylbutyryl)-
9-echimidinylretronecine
399 238 (<1), 223 (17), 222 (100), 221 (7), 143 (49), 138 (4), 137 (5), 136 (33), 121 (16), 120 (62),
119 (17), 106 (5), 94 (34), 93 (47), 85 (12), 80 (11), 57 (20), 53 (3), 43 (9), 41 (5).
2
a 1 – El-Shazly et al., 1996a; 2 – El-Shazly et al., 1996b; 3 – Witte et al., 1993.
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Fig. 1. Structures of PAs found in E. hypertropicum and E. stenosiphon subsp. stenosiphon.
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unsaturated monoesters and open chain diesters PAs (El-Shazly et al., 1996a; Mehrabani et al., 2006). From among the Echium
genera, the most frequently identiﬁed PAwas echimidine (V) as described from Echium amoenum (Mehrabani et al., 2006), E.
horridum, E. humile (El-Shazly et al., 1996b, 1999), E. pininana (Roeder et al., 1991), E. plantagineum (Culvenor, 1956, Culvenor
et al., 1981; Colegate et al., 2005), Echium rauwolﬁi, E. setosum and E. vulgare (El-Shazly et al., 1996b, 1999). Moreover,
compound II had been already reported from E. glomeratum (Alali et al., 2008), E. plantagineum (Culvenor, 1956, Culvenor
et al., 1981; Colegate et al., 2005), E. setosum and E. vulgare (El-Shazly et al., 1996b). The presence of compounds III and IV
in the genus Echium has previously been described from E. horridum, E. humile (El-Shazly et al., 1996b, 1999) and E. planta-
gineum (Culvenor, 1956, Culvenor et al., 1981; Colegate et al., 2005). The identiﬁcation of the uncommon compounds I and VI
only reported in the species E. humile (El-Shazly et al., 1996b) is a strong indication that E. stenosiphon subsp. stenosiphon and
E. hypertropicum are closely related to the species E. humile.
In conclusion, E. stenosiphon subsp. stenosiphon and E. hypertropicumwere found to be rich in pyrrolizidine alkaloids (PAs)
with the common structural features i.e. 1,2 unsaturation, an esteriﬁed allylic hydroxyl group at C9 and an esteriﬁed alcoholic
hydroxyl group at C7 that generally make PAs potentially toxic (Fu et al., 2004). Thus, it would be prudent to regard these two
species as potentially hepatotoxic and using them in traditional medicine should therefore be avoided or minimized as far as
possible. In addition, PAs couldbeusedas chemotaxonomicmarkers for thegenus Echium, serving to assist taxonomistswith the
complex taxonomy of this genus. The current study is the ﬁrst report of the presence of PAs in the capeverdian Echium species.
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